Libo Pharma Corp. (TPEX:7888)
Taiwan · Delayed Price · Currency is TWD 54.70
-2.20 (-3.87%)
At close: Jan 16, 2026
Libo Pharma Market Cap
Libo Pharma has a market cap or net worth of 3.61 billion as of January 21, 2026.
Market Cap
3.61B
Enterprise Value
3.28B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
54.70
Market Cap Chart
Since December 23, 2025, Libo Pharma's market cap has increased from 3.55B to 3.61B, an increase of 1.80%. That is a compound annual growth rate of 25.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.60B | -2.64% |
| Dec 31, 2025 | 3.70B | 4.35% |
| Dec 23, 2025 | 3.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ultra Chip | 3.76B |
| Kura Sushi Asia | 3.75B |
| Intech Biopharm | 3.74B |
| Eagle Cold Storage Enterprise | 3.72B |
| Solomon Data International | 3.72B |
| ACRO Biomedical | 3.72B |
| RAC Electric Vehicles | 3.71B |
| Taiwan Kong King Co.,Ltd | 3.70B |